New treatments for visceral leishmaniasis in Africa – The story so far.

From:
Department for International Development
Published
1 January 2009
Country:
Kenya, Sudan, Ethiopia
Document Type:
Conference Paper
Theme:
Health
Authors:
Musa, A.M., Khalil, E.

Abstract

This presentation describes a clinical trial, conducted in Ethiopia, Kenya and Sudan, of the use of sodium stibogluconate (SSG), paromomycin or the 2 drugs in combination to treat visceral leishmaniasis (VL). It was found that such a trial was feasible in a rural setting, and there were comparatiively few safety concerns, but in eastern Sudan the dose of paromomycin was inadequate and had to be increased.

Citation

Presentation from ‘Improved Treatments for Visceral Leishmaniasis – Status of Ongoing Studies’. Symposium held at World Leish 4, Lucknow, India, 4 February 2009.

New treatments for visceral leishmaniasis in Africa – The story so far.

Updates to this page

Published 1 January 2009
Contents